BioClinica gets Microsoft honors; Tegal buys CollabRx;

> BioClinica ($BIOC) grabbed a Microsoft Life Sciences Innovation award with C.R. Bard. Release

> Tegal ($TGAL) has agreed to acquire CollabRx, which has a foothold in the market for data analytics in genomic medicine. Item

> Thomson Reuters releases a new software tool for pharma called Cortellis for Regulatory Intelligence. Announcement

> Here's one last taste of the news out of the 2012 DIA meeting last week from Outsourcing-Pharma. Report

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.